Aetion Stock
Analytics Solutions for Life Sciences
Sign up today and learn more about Aetion Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Aetion Stock
Based in New York City, Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based care. With its patented rapid-cycle analytics™ technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care. The company is backed by Flare Capital Partners, Lakestar, Oxeon Ventures and other leading individual health technology investors. Learn more at www.aetion.com.
Investors
New Enterprise Associates
Robinhood, Databricks, Jet, TAE Technologies, Scopely, Bloom Energy, Opendoor, Radiology Partners, DataRobot, Tempus
Amgen Ventures
Flare Capital Partners
McKesson Ventures
Funding History
February 2017 | $13.1M |
---|---|
January 2018 | $36.4M |
December 2018 | $46.2M |
April 2021 | $110M |
Management
Chief Executive Officer
Carolyn Magill
Chief Financial Officer
TC Fleming
Chief Technology Officer
John Turek
Press
prnewswire - May, 8 2023
Aetion® Launches New Application for Descriptive Analytics and Fast, Reliable Insightsmobihealthnews - Jan, 24 2023
Aetion, FDA partner on oncology real-world dataprnewswire - Nov, 8 2022
Aetion Expands Executive Team with Three New Leadersprnewswire - Aug, 4 2022
Evio & Aetion Partner to Deliver Real-World Evidence (RWE) Across the Pharmacy Value Chainprnewswire - Jan, 4 2022
Aetion acquires synthetic data trailblazer Replica Analytics